Evaluation of an 18F-labeled oligonucleotide probe targeting p21(WAF1) transcriptional changes in human tumor cells

I Koslowsky1, S Shahhosseini, R Mirzayans

  • 1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.

Oncology Research
|July 23, 2011
PubMed

Insights

This study developed 18F-labeled antisense oligonucleotides (asODNs) to image gene expression, showing they effectively target p21 mRNA in cancer cells. Liposome delivery enhanced uptake, suggesting potential for monitoring early tumor response to radiation therapy.

Area of Science:

  • Molecular Imaging
  • Radiochemistry
  • Cancer Biology

Background:

  • Monitoring early tumor response to radio- or chemotherapy is crucial for effective cancer treatment.
  • Imaging gene expression using 18F-labeled antisense oligonucleotides (asODNs) could provide insights into treatment efficacy.
  • Upregulation of p21 mRNA post-irradiation is a marker for accelerated cellular senescence, indicating early tumor response.

Purpose of the Study:

  • To evaluate the in vitro uptake and distribution of a novel (radio)-fluorinated asODN targeting p21 mRNA in HCT116 human colon carcinoma cells.
  • To assess the antisense activity and cellular localization of the radiolabeled probe.
  • To investigate the effect of liposomal delivery on the probe's cellular penetration and distribution.

Main Methods:

  • Conjugation of a (radio)fluorine prosthetic group to asODN and a random sequence oligonucleotide (rsODN).
  • Treatment of irradiated HCT116 cells with naked or liposome-transfected ODNs.
  • Cellular uptake and distribution analysis using cell fractionation, confocal microscopy, immunofluorescence, and Western blot.

Main Results:

  • The 18F-labeled asODN ([F]asODN) exhibited comparable antisense binding to p21 mRNA as unlabeled asODN.
  • Liposomal delivery significantly increased the uptake of [18F]ODNs (asODN and rsODN) by three- to fivefold compared to naked [18F]ODNs.
  • Transfected [18F]asODN showed increased cytoplasmic and endosomal distribution over time, suggesting availability for mRNA targeting, while [18F]rsODN and naked ODNs did not exhibit altered distribution.

Conclusions:

  • The addition of a fluorine moiety did not compromise the antisense activity or cellular accumulation/distribution of the ODNs.
  • Radiolabeled ODNs, particularly when delivered via liposomes, effectively penetrate cancer cells.
  • The observed cytoplasmic distribution of [18F]asODN supports its potential for imaging accelerated cellular senescence following irradiation, warranting further investigation.